[go: up one dir, main page]

FI792567A7 - Nya spiro-oxazolidinoner - Google Patents

Nya spiro-oxazolidinoner

Info

Publication number
FI792567A7
FI792567A7 FI792567A FI792567A FI792567A7 FI 792567 A7 FI792567 A7 FI 792567A7 FI 792567 A FI792567 A FI 792567A FI 792567 A FI792567 A FI 792567A FI 792567 A7 FI792567 A7 FI 792567A7
Authority
FI
Finland
Prior art keywords
oxazolidinoner
new spiro
spiro
new
Prior art date
Application number
FI792567A
Other languages
English (en)
Other versions
FI65255C (fi
FI65255B (fi
Inventor
Rodney Caughren Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI792567A7 publication Critical patent/FI792567A7/fi
Application granted granted Critical
Publication of FI65255B publication Critical patent/FI65255B/fi
Publication of FI65255C publication Critical patent/FI65255C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Photosensitive Polymer And Photoresist Processing (AREA)
  • Moulding By Coating Moulds (AREA)
  • Dental Preparations (AREA)
FI792567A 1978-08-21 1979-08-17 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara spiro(4h-2,3-dihydrobenzopyran(4,5')oxazolidin)-2',4'-dioner FI65255C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/935,199 US4200642A (en) 1978-08-21 1978-08-21 Spiro-oxazolidindiones
US93519978 1978-08-21

Publications (3)

Publication Number Publication Date
FI792567A7 true FI792567A7 (fi) 1980-02-22
FI65255B FI65255B (fi) 1983-12-30
FI65255C FI65255C (fi) 1984-04-10

Family

ID=25466700

Family Applications (1)

Application Number Title Priority Date Filing Date
FI792567A FI65255C (fi) 1978-08-21 1979-08-17 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara spiro(4h-2,3-dihydrobenzopyran(4,5')oxazolidin)-2',4'-dioner

Country Status (34)

Country Link
US (1) US4200642A (fi)
JP (4) JPS6011914B2 (fi)
AR (1) AR225614A1 (fi)
AT (1) AT366689B (fi)
AU (1) AU535170B2 (fi)
BE (1) BE878311A (fi)
CA (1) CA1121361A (fi)
CH (1) CH639974A5 (fi)
CS (1) CS208129B2 (fi)
DD (1) DD146602A5 (fi)
DE (2) DE2933441C2 (fi)
DK (1) DK258479A (fi)
EG (1) EG14639A (fi)
ES (1) ES483511A1 (fi)
FI (1) FI65255C (fi)
FR (3) FR2442851A1 (fi)
GB (2) GB2028318B (fi)
GR (1) GR71913B (fi)
HU (1) HU179746B (fi)
IE (1) IE48932B1 (fi)
IL (1) IL58076A (fi)
IN (1) IN152416B (fi)
IT (1) IT1123536B (fi)
LU (1) LU81613A1 (fi)
NL (1) NL7906318A (fi)
NO (1) NO792699L (fi)
NZ (1) NZ191350A (fi)
PH (1) PH18091A (fi)
PL (1) PL130686B1 (fi)
PT (1) PT70086A (fi)
SE (1) SE447116B (fi)
SU (1) SU942597A3 (fi)
YU (1) YU41488B (fi)
ZA (1) ZA794379B (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4329459A (en) * 1980-05-05 1982-05-11 The Upjohn Company Tetrahydrobenzopyran derivatives
SG56656G (en) * 1980-07-28 1987-03-27 Pfizer Hypoglycemic 5-substituted oxazolidine-2, 4-diones
US4367234A (en) * 1980-07-28 1983-01-04 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
ES8400116A1 (es) * 1981-10-13 1983-10-16 Pfizer "un procedimiento por analogia para la preparacion de derivados de espiro-oxindol-oxazolidindiona".
US4436745A (en) 1982-04-15 1984-03-13 Alcon Laboratories, Inc. Method of inhibiting aldose reductase activity
US4464385A (en) * 1982-04-15 1984-08-07 Alcon Laboratories, Inc. Treatment of diabetic complications with hydantoins
US4438272A (en) 1982-04-15 1984-03-20 Alcon Laboratories, Inc. Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
ZA832679B (en) * 1982-05-07 1983-12-28 Ici Plc Indoline derivatives
US4430337A (en) * 1982-06-23 1984-02-07 Pfizer Inc. Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic activity
US4556670A (en) * 1982-12-06 1985-12-03 Pfizer Inc. Spiro-3-hetero-azolones for treatment of diabetic complications
US4533667A (en) * 1983-05-25 1985-08-06 Pfizer Inc. Imidazolidinedione derivatives
US4464380A (en) * 1983-05-25 1984-08-07 Pfizer Inc. Imidazolidinedione derivatives
DK277484A (da) * 1983-06-23 1984-12-24 Hoffmann La Roche Thiazolidinderivater
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―3―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
DE3522791C1 (en) * 1985-06-26 1987-01-02 Ferroplast Gmbh Positioning wall for lagging a cavity to be filled with a hardenable material in mining or tunnelling
US4853410A (en) * 1986-01-17 1989-08-01 Pfizer Inc. Hydroxyacetic acid derivatives for the treatment of diabetic complications
US5039672A (en) * 1990-04-05 1991-08-13 Pfizer Inc. Heterocyclic compounds as aldose reductase inhibitors
US5068332A (en) * 1990-10-12 1991-11-26 American Home Products Corporation Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors
US5102886A (en) * 1990-10-12 1992-04-07 American Home Products Corporation 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors
FR2707981B1 (fr) * 1993-07-20 1995-09-01 Adir Nouveaux dérivés de benzospiroalcène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2725206B1 (fr) * 1994-09-29 1996-12-06 Roussel Uclaf Nouvelles imidazolidines substituees par un heterocycle, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
AU773505B2 (en) 1999-06-18 2004-05-27 Merck & Co., Inc. Arylthiazolidinedione and aryloxazolidinedione derivatives
EP1194147B1 (en) 1999-06-18 2007-01-10 Merck & Co., Inc. Arylthiazolidinedione and aryloxazolidinedione derivatives
ITPI20060083A1 (it) * 2006-07-11 2008-01-12 Univ Pisa Derivati 2,2-dimetilcromanici 4-spiro-eterocicilici azotati (a 5 e 6 termini) n-sostituiti quali cardio-protettori nei confronti dell'insulto ischemico
USD775790S1 (en) * 2015-11-18 2017-01-10 Ginger Damon Motorcycle jacket
JP7150023B2 (ja) 2017-12-21 2022-10-07 エシティ・ハイジーン・アンド・ヘルス・アクチエボラグ 吸収性物品
CN111465377A (zh) 2017-12-21 2020-07-28 易希提卫生与保健公司 包括强壮的通道密封结合的吸收性物品
CA3217324A1 (en) * 2021-04-30 2022-11-03 Xiangtian ZHOU Method and pharmaceutical composition for treating myopia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1204232B (de) * 1959-07-16 1965-11-04 Ncr Co Verfahren zur Herstellung von Derivaten von 3-Alkyl-3'-methyl-spiro[benzoxazolin-2, 2'-(2'H-1'-benzopyran)]
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents

Also Published As

Publication number Publication date
GB2028318A (en) 1980-03-05
IE791592L (en) 1980-02-21
NL7906318A (nl) 1980-02-25
DD146602A5 (de) 1981-02-18
NZ191350A (en) 1984-04-27
NO792699L (no) 1980-02-22
IT1123536B (it) 1986-04-30
LU81613A1 (fr) 1980-04-21
CS208129B2 (en) 1981-08-31
SE7906949L (sv) 1980-02-22
DE2953954C2 (fi) 1987-12-03
JPS5946517B2 (ja) 1984-11-13
JPS55129280A (en) 1980-10-06
PT70086A (en) 1979-09-01
DE2953954A1 (fi) 1982-09-02
ZA794379B (en) 1980-08-27
AT366689B (de) 1982-04-26
HU179746B (en) 1982-12-28
FR2442851A1 (fr) 1980-06-27
PL217881A1 (fi) 1981-01-02
GB2033904B (en) 1982-08-04
FI65255C (fi) 1984-04-10
EG14639A (en) 1985-03-31
CA1121361A (en) 1982-04-06
DE2933441A1 (de) 1980-02-28
FR2440949B1 (fi) 1981-06-12
SE447116B (sv) 1986-10-27
PL130686B1 (en) 1984-08-31
AU5009279A (en) 1980-02-28
FR2442851B1 (fi) 1983-06-17
YU199979A (en) 1983-06-30
ES483511A1 (es) 1980-09-01
FR2440950A1 (fr) 1980-06-06
FR2440949A1 (fr) 1980-06-06
GB2028318B (en) 1982-08-04
SU942597A3 (ru) 1982-07-07
JPS5528996A (en) 1980-02-29
GB2033904A (en) 1980-05-29
IN152416B (fi) 1984-01-07
DE2933441C2 (de) 1987-04-23
JPS55129288A (en) 1980-10-06
CH639974A5 (fr) 1983-12-15
BE878311A (fr) 1980-02-20
PH18091A (en) 1985-03-20
IL58076A (en) 1982-07-30
YU41488B (en) 1987-08-31
FR2440950B1 (fi) 1981-06-12
IL58076A0 (en) 1979-12-30
JPS5943954B2 (ja) 1984-10-25
IE48932B1 (en) 1985-06-26
JPS6011914B2 (ja) 1985-03-28
AU535170B2 (en) 1984-03-08
AR225614A1 (es) 1982-04-15
ATA560579A (de) 1981-09-15
JPS6011915B2 (ja) 1985-03-28
IT7925182A0 (it) 1979-08-20
FI65255B (fi) 1983-12-30
JPS55129279A (en) 1980-10-06
US4200642A (en) 1980-04-29
DK258479A (da) 1980-02-22
GR71913B (fi) 1983-08-16

Similar Documents

Publication Publication Date Title
FI790640A7 (fi) Nya resorberbara galeniska kompositioner
FI792356A7 (fi) Nya n-substituerade heterocyckler
FI791084A7 (fi) Nya n-heterocyklo-4-piperidinaminer
FI791754A7 (fi) Nya aminotiazoler
FI792567A7 (fi) Nya spiro-oxazolidinoner
FI792628A7 (fi) Nya benzimidazolider deras framstaellning och deras anvaendning saosom laekemedel
FI793142A7 (fi) Nya metaboliter deras framstaellning och anvaendning
FI783115A7 (fi) Aoterfoerslutbar multipelfoerpackning foer i synnerhet vaotservetter
FI792315A7 (fi) Nya staerkelser innehaollande livsmedelsprodukter och foerfarande foer deras framstaellning
FI792347A7 (fi) Nya indanylderivat deras framstaellning och anvaendning
FI792080A7 (fi) Framstaellning av nya fenetanolaminer
FI791158A7 (fi) Foerfarande foer framstaellning av nya merkaptoimidazolderivat
FI790181A7 (fi) Nya substituerade heterocykliska bensamider foerfaranden foer deras framstaellning och deras anvaendning
FI791421A7 (fi) Nya laktam-n-aettiksyror och deras amider
FI65844B (fi) Virvelluftsrenar- och dimeliminatorenhet foer en gasturbinmotor i marint bruk
FI790510A7 (fi) Nya substituerade 2-fenylimino-imidazolidiner deras syraadditionssalter dessa foereningar innehaollande laekemedel och deras framstaellningsfoerfarande
FI790740A7 (fi) Foerfarande foer framstaellning av nya karbamid- och amidofoereningar
FI792927A7 (fi) Nya galeniska laekemedelsdoseringsformer och foerfarande foer deras framstaellning
FI803403L (fi) Nya pyridotienotriaziner
SE7907312L (sv) Nya 1,2-dioxialkylenbensenderivat
SE7909023L (sv) Nya azolylketaler
FI790820A7 (fi) Foerfarande foer framstaellning av nya n-fenylalaninderivat
FI791733A7 (fi) Nya metaboliter deras framstaellning och anvaendning
FI790285A7 (fi) Foerfarande foer framstaellning av nya purinderivat
FI784017A7 (fi) Foerfarande foer framstaellning av nya arylaminoimidazolinderivater

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: PFIZER INC.